2,798 research outputs found

    Clinical Characterization of Alzheimer's Disease: Reliability of 'Age at Onset' and a New Descriptor, 'Age at Shift'

    Full text link
    To determine the interrater reliability of clinical descriptors for Alzheimer's disease (AD), we assessed the degree of agree ment among four clinicians who rated 21 patients during a longitudinal study. Despite variability in response patterns, degree of agreement for determining age at onset of dementia was statistically significant (P < 0.005). We also found significant agreement (P < 0.0001) among three clinicians for the clinical descriptor, "age at shift" from questionable to probable AD, according to the National Institutes of Health Consensus Criteria. These data demonstrate that both retro spective and prospective descriptors can be reliably determined in the clinical assessment of AD. (J Geriatr Psychiatry Neurol 1988;1:207-211).Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/68908/2/10.1177_089198878800100404.pd

    Posterior cingulate cortex in Alzheimer's disease

    Full text link
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/31318/1/0000227.pd

    In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease

    Full text link
    To map presynaptic cholinergic terminal densities in normal aging (n = 36), Alzheimer's disease (AD) (n = 22), and Parkinson's disease (PD) (n = 15), we performed single-photon emission computed tomography using [ 123 I]iodoben-zovesamicol (IBVM), an in vivo marker of the vesicular acetylcholine transporter. We used coregistered positron emission tomography with [ 18 F]fluorodexyglucose for metabolic assessment and coregistered magnetic resonance imaging for atrophy assessment. In controls (age, 22–91 years), cortical IBVM binding declined only 3.7% per decade. In AD, cortical binding correlated inversely with dementia severity. In mild dementia, binding differed according to age of onset, but metabolism did not. With an onset age of less than 65 years, binding was reduced severely throughout the entire cerebral cortex and hippocapus (about 30%), but with an onset age of 65 years or more, binding reductions were restricted to temporal cortex and hippocampus. In PD without dementia, binding was reduced only in parietal and occipital cortex, but demented PD subjects had extensive cortical binding decreases similar to early-onset AD. We conclude that cholinergic neuron integrity can be monitored in living AD and PD patients, and that it is not so devastated in vivo as suggested by postmortem choline acetylransferase activity (50–80%).Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/50361/1/410400309_ftp.pd

    Willing and able: action-state orientation and the relation between procedural justice and employee cooperation

    Get PDF
    Existing justice theory explains why fair procedures motivate employees to adopt cooperative goals, but it fails to explain how employees strive towards these goals. We study self-regulatory abilities that underlie goal striving; abilities that should thus affect employees’ display of cooperative behavior in response to procedural justice. Building on action control theory, we argue that employees who display effective self-regulatory strategies (action oriented employees) display relatively strong cooperative behavioral responses to fair procedures. A multisource field study and a laboratory experiment support this prediction. A subsequent experiment addresses the process underlying this effect by explicitly showing that action orientation facilitates attainment of the cooperative goals that people adopt in response to fair procedures, thus facilitating the display of actual cooperative behavior. This goal striving approach better integrates research on the relationship between procedural justice and employee cooperation in the self-regulation and the work motivation literature. It also offers organizations a new perspective on making procedural justice effective in stimulating employee cooperation by suggesting factors that help employees reach their adopted goals

    Evaluation of Ralgro® on pasture and subsequent feedlot performance and carcass merit of mexican crossbred steers

    Get PDF
    A pasture/feedlot field study was conducted to evaluate the effects of a single Ralgro® implant during the stocker phase on steer grazing performance and subsequent feedlot performance and carcass merit. A total of 2,764 steers of Mexican origin averaging 449 lb were assembled in Texas and shipped to Kansas, where they grazed on three intensively-early-stocked Flint Hills pastures. At initial processing, the steers were individually weighed and randomly assigned to either a non-implanted control group or a Ralgro implant group. Ralgro steers gained more (23 lb; P<0.01) than controls during the 82- to 93-day grazing phase. Following the grazing phase, all steers were shipped to a commercial feedlot in southwestern Kansas where steers from each pasture were individually weighed and given a single Component E-S® implant. Immediately after processing, steers from each pasture were sorted into either a light- or heavy-weight pen, regardless of pasture implant treatment, resulting in six feedlot pens. Days on feed ranged from 127 to 197. Control steers gained faster (P<0.01) during the feedlot phase; however, Ralgro steers had higher cumulative weight gains across the combined pasture and feedlot phases (P<0.01) and averaged three fewer days on feed (P<0.05). There were no significant differences for marbling, fat thickness, ribeye area, KPH fat, or yield grade. Ralgro steers had lower (P<0.05) quality grades because of a higher incidence (P<0.001) of steers with B and C carcass maturities

    Mouse brain distribution of a carbon-11 labeled vesamicol derivative: Presynaptic marker of cholinergic neurons

    Full text link
    The regional mouse brain distribution of a new carbon-11 labeled derivative of vesamicol, [11C]-5-(N-methylamino)benzovesamicol ([11C]MABV) is reported. Radiotracer concentrations in vivo are in the rank order of striatum&gt;cortex&gt;hippocampus&gt;hypothalamus&gt; cerebellum, consistent with reported distributions of other presynaptic cholinergic neuronal markers. In time course studies, striatum/cerebellum and cortex/cerebellum ratios for (-)-[11C]MABV continue to increase to values of 13 and 5, respectively, 75 min after i.v. injection of [11C]MABV. The specific binding in striatum and cortex is lowered by pretreatment with (+/-)-vesamicol, and shows stereoselectivity with lower uptake and lower ratios for the (+)-enantiomer. (-)-[11C]MABV is proposed as a positron-emitting radioligand for the in vivo study of presynaptic cholinergic neurons.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/28961/1/0000798.pd
    • …
    corecore